Ms Demaris Tisdale, MSW | |
69 Barre St, Montpelier, VT 05602-3504 | |
(802) 229-2770 | |
Not Available |
Full Name | Ms Demaris Tisdale |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 69 Barre St, Montpelier, Vermont |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043339773 | NPI | - | NPPES |
0009816 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 089-0000231 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Demaris Tisdale, MSW 1125 Snipe Ireland Rd, Richmond, VT 05477-9691 Ph: (802) 434-3941 | Ms Demaris Tisdale, MSW 69 Barre St, Montpelier, VT 05602-3504 Ph: (802) 229-2770 |
News Archive
The enzyme that makes fireflies glow is lighting up the scientific path toward a long-sought new medical imaging agent to better monitor treatment with heparin, the blood thinner that millions of people take to prevent or treat blood clots, scientists are reporting. Their study appears in the ACS' monthly journal Bioconjugate Chemistry.
A team of researchers led by Boston University School of Medicine (BUSM), has found treatment of selected immunoglobulin light chain (AL) amyloidosis patients with high-dose melphalan and autologous stem cell transplantation (HDM/SCT) resulted in a high organ response rate and increased overall survival (OS), even for those patients who did not achieve a hematologic complete response.
Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the completion of a private placement of its common stock and warrants representing an initial investment of $87,500, with an additional $87,500 should the warrants be exercised, by a group of private investors who previously purchased the Company's stock at a 36% lower price, through a prior private placement. Please see the associated Form 8-K for additional details regarding this transaction.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products, today announced that The Journal of Hand Surgery (JHS) has published in its December 2010 online edition pivotal CORD II phase III clinical trial of XIAFLEX (collagenase clostridium histolyticum), a novel, first-in-class biologic, conducted by BioSpecifics' strategic partner Auxilium Pharmaceuticals Inc., for the nonsurgical treatment of adult Dupuytren's contracture patients with a palpable cord.
There are a number of measures to assess aspects of primary care, but a new measure breaks new ground by combining experiences of patients, clinicians, and payers and allowing the most informed reporter-the patient-to assess vital primary care functions that are often missed.
› Verified 8 days ago
Ms. Jennifer Ivy Gordon, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 156 Main St, Montpelier, VT 05602 Phone: 802-223-4738 Fax: 802-223-6067 | |
Dillon Teachout Burns, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 162 Elm St, Montpelier, VT 05602 Phone: 802-391-9002 | |
Alison Cook Anderson, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 15 State St, Montpelier, VT 05602 Phone: 802-229-6200 | |
Ms. Gretchen Holly Baumgardner X, L.I.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 58 College St, #1, Montpelier, VT 05602 Phone: 802-229-2562 | |
Laura Carolyn Sturgis, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 39 Court St, Montpelier, VT 05602 Phone: 802-272-4438 | |
Jamie Anne Spector, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 174 Elm St, Montpelier, VT 05602 Phone: 510-846-8806 |